Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Profit After Tax: 2022-2025

Historic Profit After Tax for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Profit After Tax fell 152.45% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 74.51%. This contributed to the annual value of -$9.0 million for FY2024, which is 13.89% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Profit After Tax stood at -$5.1 million, which was down 24.39% from -$4.1 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Profit After Tax registered a high of -$88,052 during Q2 2022, and its lowest value of -$5.1 million during Q3 2025.
  • Moreover, its 3-year median value for Profit After Tax was -$2.3 million (2023), whereas its average is -$2.6 million.
  • Over the last 5 years, bioAffinity Technologies' Profit After Tax had its largest YoY gain of 53.43% in 2023, and its largest YoY loss of 1,876.30% in 2023.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Profit After Tax stood at -$1.7 million in 2022, then slumped by 41.72% to -$2.4 million in 2023, then decreased by 25.02% to -$3.0 million in 2024, then crashed by 152.45% to -$5.1 million in 2025.
  • Its Profit After Tax was -$5.1 million in Q3 2025, compared to -$4.1 million in Q2 2025 and -$2.7 million in Q1 2025.